Category: Exchange Filings
Vancouver, Canada, December 2, 2013, Medgold Resources Corp. (TSX-V: MED) advises that its previously announced share consolidation was approved by the shareholders of the Company at the annual and special meeting held on November 27, 2013, and will take effect at market opening today. Every three previous common shares of the Company will be exchanged for one new common share of the Company, resulting in a total issued capital of 17,472,029 shares. The Company’s name and trading symbol remain the same; only the CUSIP number of the common shares has[…]
Written by Medgold Resources on December 2, 2013
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Nov. 4, 2013) – Medgold Resources Corp. (TSX VENTURE:MED) announces that due to current market conditions, it has cancelled the private placement financing proposed in the Company’s news release of September 16, 2013. Based on comments received from potential participants in the cancelled financing, Medgold’s Board of Directors believes that to facilitate future equity financings for the Company and to attract new business opportunities, it may be necessary to consolidate the share capital on the basis of one new share for up to three existing shares.[…]
Written by Medgold Resources on November 4, 2013
VANCOUVER, BRITISH COLUMBIA–(Marketwired – Sept. 13, 2013) – Medgold Resources Corp. (TSX VENTURE:MED) announces that its Board of Directors has determined that it is in the best interests of the Company to amend the exercise price of private placement warrants issued earlier this year. Accordingly, subject to TSX Venture Exchange acceptance, the exercise price of outstanding warrants entitling the holders to purchase a total of 6,500,000 shares has been reduced from $0.15 per share to $0.06 per share. The expiry date of these warrants remain unchanged. If, however, at any[…]
Written by Medgold Resources on September 13, 2013
TSX-V: MED VANCOUVER, Feb. 8, 2013 /CNW/ – Medgold Resources Corp. (TSX-V: MED), the European focused gold exploration company, is pleased to announce that it has arranged, subject to Exchange approval, a $975,000 non-brokered private placement financing of debentures which are convertible into 6,500,000 common shares of the Company at the rate of $0.15 per share. The debentures will bear interest at the rate of 8% per annum and are convertible into shares for a period of up to two years from closing of the financing. The debenture holders will[…]
Written by Medgold Resources on February 8, 2013
VANCOUVER, Dec. 11, 2012 /CNW/ – Emerick Resources Corp. (TSX-V: ERC.H) (“Emerick” or the “Company”) is pleased to announce that it has completed its reverse takeover (“RTO”) of Medgold Resource Ltd. (“Medgold”), a private European-focused gold exploration company. Subject to TSX Venture Exchange acceptance, the Company’s shares will trade under the name, Medgold Resources Corp. The newly merged company will explore for major gold deposits in the Mediterranean region, focusing on countries with a known history of gold production, and mining-friendly legal/fiscal codes. The Company’s project portfolio includes gold projects[…]
Written by Medgold Resources on December 11, 2012
